The contributions of oxytocin and vasopressin pathway genes to human behavior

Hormones and Behavior

Volumn 61, Issue 3, 2012, Pages 359-379

  Ebstein, Richard P ^a,b   Knafo, Ariel ^b   Mankuta, David ^b   Chew, Soo Hong ^a   Lai, Poh San ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

ADP ribosyl cyclase (CD38); Arginine receptor 1b receptor (AVPR1b); Arginine vasopressin 1a receptor (AVPR1a); LNPEP (oxytocinase); Neurophysin; Oxytocin; Oxytocin receptor (OXTR); Plasma oxytocin; Polymorphism; Vasopressin

Indexed keywords

ARGIPRESSIN; CD38 ANTIGEN; CYSTYL AMINOPEPTIDASE; OXYTOCIN; OXYTOCIN RECEPTOR; RETINOIC ACID; VASOPRESSIN;

ADP RIBOSYL CYCLASE GENE; AGGRESSION; ARGININE VASOPRESSIN 1A RECEPTOR GENE; ARGININE VASOPRESSIN 1B RECEPTOR GENE; ARGININE VASOPRESSIN GENE; AUTISM; BEHAVIOR; BEHAVIOR GENETICS; CD38 GENE; DANCING; DEPRESSION; FEEDING BEHAVIOR; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOMICS; GENOTYPE; HUMAN; HUMAN GENOME; LNPEP GENE; LYMPHOBLASTOID CELL; MICROSATELLITE MARKER; MOLECULAR GENETICS; MUSIC; NEUROECONOMICS; NEUROIMAGING; NEUROSCIENCE; NONHUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN GENE; OXYTOCIN RECEPTOR GENE; OXYTOCIN RELEASE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL ADAPTATION; SOCIAL BEHAVIOR; SOCIAL COGNITION; SUBSTANCE ABUSE; SUPRAOPTIC NUCLEUS;

ANIMALS; ANTIGENS, CD38; AUTISTIC DISORDER; DANCING; FEEDING BEHAVIOR; GENE EXPRESSION; GENOMICS; HUMANS; MICROSATELLITE REPEATS; MUSIC; OXYTOCIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; RETINOIDS; SOCIAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; VASOPRESSINS;

EID: 84858643265     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2011.12.014     Document Type: Review

References (306)

1. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., Chai S.Y. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 2001, 276:48623-48626.
2. Albiston A.L., Mustafa T., McDowall S.G., Mendelsohn F.A., Lee J., Chai S.Y. AT4 receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement. Trends Endocrinol. Metab. 2003, 14:72-77.
3. Albiston A.L., Morton C.J., Ng H.L., Pham V., Yeatman H.R., Ye S., Fernando R.N., De Bundel D., Ascher D.B., Mendelsohn F.A., Parker M.W., Chai S.Y. Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase. FASEB J. 2008, 22:4209-4217.
4. Allen-Brady K., Miller J., Matsunami N., Stevens J., Block H., Farley M., et al. A high-density SNP genome-wide linkage scan in a large autism extended pedigree. Mol. Psychiatry 2009, 14(6):590-600.
5. Andari E., Duhamel J.R., Zalla T., Herbrecht E., Leboyer M., Sirigu A. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:4389-4394.
6. Apicella C.L., Cesarini D., Johannesson M., Dawes C.T., Lichtenstein P., Wallace B., Beauchamp J., Westberg L. No association between oxytocin receptor (OXTR) gene polymorphisms and experimentally elicited social preferences. PLoS One 2010, 5:e11153.
7. Arenas M., Fairbanks L.D., Vijayakumar K., Carr L., Escuredo E., Marinaki A.M. An unusual genetic variant in the MOCS1 gene leads to complete missplicing of an alternatively spliced exon in a patient with molybdenum cofactor deficiency. J. Inherit. Metab. Dis. 2009, 32:560-569.
8. Ariely D., Norton M.I. Psychology and experimental economics: a gap in abstraction. Curr. Dir. Psychol. Sci. 2007, 16:336-339.
9. Atladottir H.O., Pedersen M.G., Thorsen P., Mortensen P.B., Deleuran B., Eaton W.W., Parner E.T. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009, 124:687-694.
10. Avinun R., Israel S., Shalev I., Gritsenko I., Bornstein G., Ebstein R.P., Knafo A. AVPR1A variant associated with preschoolers' lower altruistic behavior. PLoS One 2011, 6:e25274.
11. Bachner-Melman R., Zohar A.H., Elizur Y., Nemanov L., Gritsenko I., Konis D., Ebstein R.P. Association between a vasopressin receptor AVPR1A promoter region microsatellite and eating behavior measured by a self-report questionnaire (Eating Attitudes Test) in a family-based study of a nonclinical population. Int. J. Eat. Disord. 2004, 36:451-460.
12. Bachner-Melman R., Dina C., Zohar A.H., Constantini N., Lerer E., Hoch S., Sella S., Nemanov L., Gritsenko I., Lichtenberg P., Granot R., Ebstein R.P. AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance. PLoS Genet. 2005, 1:e42.
13. Bachner-Melman R., Zohar A.H., Bacon-Shnoor N., Elizur Y., Nemanov L., Gritsenko I., Ebstein R.P. Linkage between vasopressin receptor AVPR1A promoter region microsatellites and measures of social behavior in humans. J. Individ. Differ. 2005, 26:2-10.
14. Bachner-Melman R., Zohar A.H., Nemanov L., Heresco-Levy U., Gritsenko I., Ebstein R.P. Association between the insulin-like growth factor 2 gene (IGF2) and scores on the eating attitudes test in nonclinical subjects: a family-based study. Am. J. Psychiatry 2005, 162:2256-2262.
15. Bachner-Melman R., Zohar A.H., Ebstein R.P. An examination of cognitive versus behavioral components of recovery from anorexia nervosa. J. Nerv. Ment. Dis. 2006, 194:697-703.
16. Bachner-Melman R., Zohar A.H., Ebstein R.P., Elizur Y., Constantini N. How anorexic-like are the symptom and personality profiles of aesthetic athletes?. Med. Sci. Sports Exerc. 2006, 38:628-636.
17. Bachner-Melman R., Lerer E., Zohar A.H., Kremer I., Elizur Y., Nemanov L., et al. Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4). Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(6):748-756.
18. Bachner-Melman R., Zohar A.H., Ebstein R.P., Bachar E. The relationship between selflessness levels and the severity of anorexia nervosa symptomatology. Eur. Eat. Disord. Rev. 2007, 15:213-220.
19. Bachner-Melman R., Zohar A.H., Elizur Y., Kremer I., Golan M., Ebstein R. Protective self-presentation style: association with disordered eating and anorexia nervosa mediated by sociocultural attitudes towards appearance. Eat. Weight Disord. 2009, 14:1-12.
20. Bachner-Melman R., Zohar A.H., Kremer I., Komer M., Blank S., Golan M., Ebstein R.P. Self-monitoring in anorexia nervosa. Int. J. Soc. Psychiatry 2009, 55:170-179.
21. Backberg M., Hervieu G., Wilson S., Meister B. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur. J. Neurosci. 2002, 15:315-328.
22. Bakermans-Kranenburg M.J., van Ijzendoorn M.H. Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting. Soc. Cogn. Affect. Neurosci. 2008, 3:128-134.
23. Baron-Cohen S., Wheelwright S., Hill J., Raste Y., Plumb I. The "Reading the Mind in the Eyes" Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J. Child Psychol. Psychiatry 2001, 42:241-251.
24. Bartz J.A., McInnes L.A. CD38 regulates oxytocin secretion and complex social behavior. Bioessays 2007, 29:837-841.
25. Bick J., Dozier M. Mothers' concentrations of oxytocin following close, physical interactions with biological and nonbiological children. Dev. Psychobiol. 2010, 52:100-107.
26. Billhult A., Lindholm C., Gunnarsson R., Stener-Victorin E. The effect of massage on cellular immunity, endocrine and psychological factors in women with breast cancer - a randomized controlled clinical trial. Auton. Neurosci. 2008, 140:88-95.
27. Binder E.B., Owens M.J., Liu W., Deveau T.C., Rush A.J., Trivedi M.H., Fava M., Bradley B., Ressler K.J., Nemeroff C.B. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Arch. Gen. Psychiatry 2010, 67:369-379.
28. Bleickardt C.J., Mullins D.E., Macsweeney C.P., Werner B.J., Pond A.J., Guzzi M.F., Martin F.D., Varty G.B., Hodgson R.A. Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior. Psychopharmacology (Berl) 2009, 202:711-718.
29. Blugeot A., Rivat C., Bouvier E., Molet J., Mouchard A., Zeau B., Bernard C., Benoliel J.J., Becker C. Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J. Neurosci. 2011, 31:12889-12899.
30. Bocchio-Chiavetto L., Zanardini R., Bortolomasi M., Abate M., Segala M., Giacopuzzi M., Riva M.A., Marchina E., Pasqualetti P., Perez J., Gennarelli M. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. Eur. Neuropsychopharmacol. 2006, 16:620-624.
31. Borg J., Simren M., Ohlsson B. Oxytocin reduces satiety scores without affecting the volume of nutrient intake or gastric emptying rate in healthy subjects. Neurogastroenterol. Motil. 2011, 23(56-61):e55.
32. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 2002, 5:514-516.
33. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
34. Braida D., Sala M., Donzelli A., Capurro V., Finardi A. Social and learning deficit, increased aggression and seizure susceptibility in otr null mice is reversed by ot/avp treatment: a model of autism 2010.
35. Buckholtz J.W., Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci. 2009, 31:120-129.
36. Buhrmester D., Furman W. Perceptions of sibling relationships during middle childhood and adolescence. Child Dev. 1990, 61:1387-1398.
37. Caldwell H.K., Wersinger S.R., Young W.S. The role of the vasopressin 1b receptor in aggression and other social behaviours. Prog. Brain Res. 2008, 170:65-72.
38. Campbell D.B., Datta D., Jones S.T., Batey Lee E., Sutcliffe J.S., Hammock E.A., Levitt P. Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder. J. Neurodev. Disord. 2011, 3:101-112.
39. Carter C.S., Pournajafi-Nazarloo H., Kramer K.M., Ziegler T.E., White-Traut R., Bello D., Schwertz D. Oxytocin: behavioral associations and potential as a salivary biomarker. Ann. N. Y. Acad. Sci. 2007, 1098:312-322.
40. Carter C.S., Grippo A.J., Pournajafi-Nazarloo H., Ruscio M.G., Porges S.W. Oxytocin, vasopressin and sociality. Prog. Brain Res. 2008, 170:331-336.
41. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., Taylor A., Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
42. Chagnon Y.C., Roy M.A., Bureau A., Merette C., Maziade M. Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes. Schizophr. Res. 2008, 100:281-290.
43. Chai S.Y., Fernando R., Peck G., Ye S.Y., Mendelsohn F.A., Jenkins T.A., Albiston A.L. The angiotensin IV/AT4 receptor. Cell. Mol. Life Sci. 2004, 61:2728-2737.
44. Chai S.Y., Yeatman H.R., Parker M.W., Ascher D.B., Thompson P.E., Mulvey H.T., Albiston A.L. Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase. BMC Neurosci. 2008, 9(Suppl 2):S14.
45. Chen F.S., Kumsta R., von Dawans B., Monakhov M., Ebstein R.P., Heinrichs M. Common oxytocin receptor gene (OXTR) polymorphism and social support interact to reduce stress in humans. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(50):19937-19942.
46. Cherkas L.F., Oelsner E.C., Mak Y.T., Valdes A., Spector T.D. Genetic influences on female infidelity and number of sexual partners in humans: a linkage and association study of the role of the vasopressin receptor gene (AVPR1A). Twin Res. 2004, 7:649-658.
47. Choleris E., Clipperton-Allen A.E., Phan A., Kavaliers M. Neuroendocrinology of social information processing in rats and mice. Front. Neuroendocrinol. 2009, 30:442-459.
48. Christensen J.H., Siggaard C., Corydon T.J., deSanctis L., Kovacs L., Robertson G.L., Gregersen N., Rittig S. Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. Eur. J. Hum. Genet. 2004, 12:44-51.
49. Cloninger C.R. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr. Dev. 1986, 4:167-226.
50. Cook E.H., Courchesne R., Lord C., Cox N.J., Yan S., Lincoln A., Haas R., Courchesne E., Leventhal B.L. Evidence of linkage between the serotonin transporter and autistic disorder. Mol. Psychiatry 1997, 2:247-250.
51. Costa B., Pini S., Gabelloni P., Abelli M., Lari L., Cardini A., et al. Oxytocin receptor polymorphisms and adult attachment style in patients with depression. Psychoneuroendocrinology 2009, 34(10):1506-1514.
52. Cottet M., Albizu L., Perkovska S., Jean-Alphonse F., Rahmeh R., Orcel H., Mejean C., Granier S., Mendre C., Mouillac B., Durroux T. Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes. Curr. Opin. Pharmacol. 2010, 10:59-66.
53. De Dreu C.K.W., Van Lange P.A.M. The impact of social value orientations on negotiator cognition and behavior. Pers. Soc. Psychol. Bull. 1995, 21:1178-1188.
54. De Luca V., Strauss J., Semeralul M., Huang S., Li P.P., Warsh J.J., Kennedy J.L., Wong A.H. Analysis of BDNF Val66Met allele-specific mRNA levels in bipolar disorder. Neurosci. Lett. 2008, 441:229-232.
55. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D., Nothen M.M., Maffei P., Franke P., Fritze J., Maier W., Propping P., Beckmann H., Bellodi L., Lesch K.P. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 1999, 8:621-624.
56. Dempster E.L., Burcescu I., Wigg K., Kiss E., Baji I., Gadoros J., Tamas Z., Kapornai K., Daroczy G., Kennedy J.L., Vetro A., Kovacs M., Barr C.L. Further genetic evidence implicates the vasopressin system in childhood-onset mood disorders. Eur. J. Neurosci. 2009, 30:1615-1619.
57. Devost D., Zingg H.H. Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer. J. Mol. Endocrinol. 2003, 31:461-471.
58. Ditzen B., Neumann I.D., Bodenmann G., von Dawans B., Turner R.A., Ehlert U., Heinrichs M. Effects of different kinds of couple interaction on cortisol and heart rate responses to stress in women. Psychoneuroendocrinology 2007, 32:565-574.
59. Domes G., Heinrichs M., Glascher J., Buchel C., Braus D.F., Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol. Psychiatry 2007, 62:1187-1190.
60. Domes G., Lischke A., Berger C., Grossmann A., Hauenstein K., Heinrichs M., Herpertz S.C. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010, 35:83-93.
61. Donaldson Z.R., Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322:900-904.
62. Ebstein R.P., Israel S., Lerer E., Uzefovsky F., Shalev I., Gritsenko I., Riebold M., Salomon S., Yirmiya N. Arginine vasopressin and oxytocin modulate human social behavior. Ann. N. Y. Acad. Sci. 2009, 1167:87-102.
63. Ebstein R.P., Mankuta D., Yirmiya N., Malavasi F. Are retinoids potential therapeutic agents in disorders of social cognition including autism?. FEBS Lett. 2011, 585:1529-1536.
64. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
65. Febo M., Numan M., Ferris C.F. Functional magnetic resonance imaging shows oxytocin activates brain regions associated with mother-pup bonding during suckling. J. Neurosci. 2005, 25:11637-11644.
66. Fehm H.L., Perras B., Smolnik R., Kern W., Born J. Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?. Eur. J. Pharmacol. 2000, 405:43-54.
67. Fehr E., Camerer C.F. Social neuroeconomics: the neural circuitry of social preferences. Trends Cogn. Sci. 2007, 11:419-427.
68. Feldman R., Weller A., Zagoory-Sharon O., Levine A. Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding. Psychol. Sci. 2007, 18:965-970.
69. Feldman R., Gordon I., Zagoory-Sharon O. The cross-generation transmission of oxytocin in humans. Horm. Behav. 2010, 58(4):669-676.
70. Ferguson J.N., Young L.J., Insel T.R. The neuroendocrine basis of social recognition. Front. Neuroendocrinol. 2002, 23:200-224.
71. Ferrero E., Malavasi F. A Natural History of the Human CD38 Gene 2002, 81-99. Kluwer Academic Publishers.
72. Frank G.K., Kaye W.H., Altemus M., Greeno C.G. CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype. Biol. Psychiatry 2000, 48:315-318.
73. Fries A.B., Ziegler T.E., Kurian J.R., Jacoris S., Pollak S.D. Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17237-17240.
74. Frydman C., Camerer C., Bossaerts P., Rangel A. MAOA-L carriers are better at making optimal financial decisions under risk. Proc. Biol. Sci. 2011, 278(1714):2053-2059.
75. Furman D.J., Chen M.C., Gotlib I.H. Variant in oxytocin receptor gene is associated with amygdala volume. Psychoneuroendocrinology 2011, 36(6):891-897.
76. Furman D.J., Chen M.C., Gotlib I.H. Variant in oxytocin receptor gene is associated with amygdala volume. Psychoneuroendocrinology 2011, 36:891-897.
77. Gard P.R. Cognitive-enhancing effects of angiotensin IV. BMC Neurosci. 2008, 9(Suppl 2):S15.
78. Gard P.R., Daw P., Mashhour Z.S., Tran P. Interactions of angiotensin IV and oxytocin on behaviour in mice. J. Renin Angiotensin Aldosterone Syst. 2007, 8:133-138.
79. Geller B., Tillman R., Badner J.A., Cook E.H. Are the arginine vasopressin V1a receptor microsatellites related to hypersexuality in children with a prepubertal and early adolescent bipolar disorder phenotype?. Bipolar Disord. 2005, 7(6):610-616.
80. Gillath O., Shaver P.R., Baek J.M., Chun D.S. Genetic correlates of adult attachment style. Pers. Soc. Psychol. Bull. 2008, 34(10):1396-1405.
81. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
82. Goldman M., Marlow-O'Connor M., Torres I., Carter C.S. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophr. Res. 2008, 98:247-255.
83. Goodson J.L. Nonapeptides and the evolutionary patterning of sociality. Prog. Brain Res. 2008, 170:3-15.
84. Goodson J.L., Bass A.H. Forebrain peptides modulate sexually polymorphic vocal circuitry. Nature 2000, 403:769-772.
85. Goodson J.L., Kingsbury M.A. Nonapeptides and the evolution of social group sizes in birds. Front. Neuroanat. 2011, 5:13.
86. Goodson J.L., Evans A.K., Bass A.H. Putative isotocin distributions in sonic fish: relation to vasotocin and vocal-acoustic circuitry. J. Comp. Neurol. 2003, 462:1-14.
87. Gordon I., Zagoory-Sharon O., Schneiderman I., Leckman J.F., Weller A., Feldman R. Oxytocin and cortisol in romantically unattached young adults: associations with bonding and psychological distress. Psychophysiology 2008, 45(3):349-352.
88. Gordon I., Zagoory-Sharon O., Leckman J.F., Feldman R. Oxytocin and the development of parenting in humans. Biol. Psychiatry 2010, 68:377-382.
89. Granot R., Frankel Y., Gritsenko V., Lerer E., Gritsenko I., Bachner-Melman R., Solomon I., Ebstein R.P. Provisional evidence that the arginine vasopressin 1a receptor gene is associated with musical memory. Evol. Hum. Behav. 2007, 28:313-318.
90. Green J.J., Hollander E. Autism and oxytocin: new developments in translational approaches to therapeutics. Neurotherapeutics 2010, 7:250-257.
91. Green L., Fein D., Modahl C., Feinstein C., Waterhouse L., Morris M. Oxytocin and autistic disorder: alterations in peptide forms. Biol. Psychiatry 2001, 50:609-613.
92. Gregory S.G., Connelly J.J., Towers A.J., Johnson J., Biscocho D., Markunas C.A., Lintas C., Abramson R.K., Wright H.H., Ellis P., Langford C.F., Worley G., Delong G.R., Murphy S.K., Cuccaro M.L., Persico A., Pericak-Vance M.A. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med. 2009, 7:62.
93. Grewen K.M., Light K.C. Plasma oxytocin is related to lower cardiovascular and sympathetic reactivity to stress. Biol. Psychol. 2011, 87(3):340-349.
94. Grewen K.M., Light K.C., Mechlin B., Girdler S.S. Ethnicity is associated with alterations in oxytocin relationships to pain sensitivity in women. Ethn. Health 2008, 13:219-241.
95. Grewen K.M., Davenport R.E., Light K.C. An investigation of plasma and salivary oxytocin responses in breast- and formula-feeding mothers of infants. Psychophysiology 2010, 47(4):625-632.
96. Grippo A.J., Cushing B.S., Carter C.S. Depression-like behavior and stressor-induced neuroendocrine activation in female prairie voles exposed to chronic social isolation. Psychosom. Med. 2007, 69:149-157.
97. Grippo A.J., Gerena D., Huang J., Kumar N., Shah M., Ughreja R., Carter C.S. Social isolation induces behavioral and neuroendocrine disturbances relevant to depression in female and male prairie voles. Psychoneuroendocrinology 2007, 32:966-980.
98. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., Hickie I.B. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 2010, 67:692-694.
99. Hammock E.A. Gene regulation as a modulator of social preference in voles. Adv. Genet. 2007, 59:107-127.
100. Hammock E.A., Young L.J. Functional microsatellite polymorphism associated with divergent social structure in vole species. Mol. Biol. Evol. 2004, 21:1057-1063.
101. Hammock E.A., Young L.J. Microsatellite instability generates diversity in brain and sociobehavioral traits. Science 2005, 308:1630-1634.
102. Hammock E.A., Young L.J. Oxytocin, vasopressin and pair bonding: implications for autism. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361:2187-2198.
103. Handlin L., Jonas W., Petersson M., Ejdeback M., Ransjo-Arvidson A.B., Nissen E., Uvnas-Moberg K. Effects of sucking and skin-to-skin contact on maternal ACTH and cortisol levels during the second day postpartum-influence of epidural analgesia and oxytocin in the perinatal period. Breastfeed. Med. 2009, 4:207-220.
104. Hariri A.R., Weinberger D.R. Imaging genomics. Br. Med. Bull. 2003, 65:259-270.
105. Heim C., Young L.J., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol. Psychiatry 2009, 14(10):954-958.
106. Heinrichs M., Meinlschmidt G., Neumann I., Wagner S., Kirschbaum C., Ehlert U., Hellhammer D.H. Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J. Clin. Endocrinol. Metab. 2001, 86:4798-4804.
107. Hernandez J., Segarra A.B., Ramirez M., Banegas I., de Gasparo M., Alba F., Vives F., Duran R., Prieto I. Stress influences brain enkephalinase, oxytocinase and angiotensinase activities: a new hypothesis. Neuropsychobiology 2009, 59:184-189.
108. Hernando F., Schoots O., Lolait S.J., Burbach J.P. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 2001, 142:1659-1668.
109. Hertwig R., Ortmann A. Experimental practices in economics: a methodological challenge for psychologists?. Behav. Brain Sci. 2001, 24:383-403. discussion 403-351.
110. Higashida H., Salmina A.B., Olovyannikova R.Y., Hashii M., Yokoyama S., Koizumi K., Jin D., Liu H.X., Lopatina O., Amina S., Islam M.S., Huang J.J., Noda M. Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochem. Int. 2007, 51:192-199.
111. Higashida H., Lopatina O., Yoshihara T., Pichugina Y.A., Soumarokov A.A., Munesue T., et al. Oxytocin signal and social behaviour: comparison among adult and infant oxytocin, oxytocin receptor and CD38 gene knockout mice. J. Neuroendocrinol. 2010, 22(5):373-379.
112. Higashida H., Yokoyama S., Munesue T., Kikuchi M., Minabe Y., Lopatina O. CD38 gene knockout juvenile mice: a model of oxytocin signal defects in autism. Biol. Pharm. Bull. 2011, 34:1369-1372.
113. Higham J.P., Barr C.S., Hoffman C.L., Mandalaywala T.M., Parker K.J., Maestripieri D. Mu-opioid receptor (OPRM1) variation, oxytocin levels and maternal attachment in free-ranging rhesus macaques Macaca mulatta. Behav. Neurosci. 2011, 125:131-136.
114. Hoge E.A., Pollack M.H., Kaufman R.E., Zak P.J., Simon N.M. Oxytocin levels in social anxiety disorder. CNS Neurosci. Ther. 2008, 14:165-170.
115. Hollander E., Novotny S., Hanratty M., Yaffe R., DeCaria C.M., Aronowitz B.R., Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 2003, 28:193-198.
116. Hollander E., Bartz J., Chaplin W., Phillips A., Sumner J., Soorya L., Anagnostou E., Wasserman S. Oxytocin increases retention of social cognition in autism. Biol. Psychiatry 2007, 61:498-503.
117. Holt-Lunstad J., Birmingham W., Light K.C. The influence of depressive symptomatology and perceived stress on plasma and salivary oxytocin before, during and after a support enhancement intervention. Psychoneuroendocrinology 2011, 36(8):1249-1256.
118. Horvath S., Xu X., Laird N. The family based association test method: strategies for studying general genotype-phenotype associations. Euro J Hum Gen 2001, 9:301-306.
119. Hu V.W., Nguyen A., Kim K.S., Steinberg M.E., Sarachana T., Scully M.A., Soldin S.J., Luu T., Lee N.H. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One 2009, 4:e5775.
120. Iacoboni M., Dapretto M. The mirror neuron system and the consequences of its dysfunction. Nat. Rev. Neurosci. 2006, 7:942-951.
121. Impey S., McCorkle S.R., Cha-Molstad H., Dwyer J.M., Yochum G.S., Boss J.M., McWeeney S., Dunn J.J., Mandel G., Goodman R.H. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 2004, 119:1041-1054.
122. Inenaga K., Yamashita H. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin. J. Physiol. 1986, 370:165-180.
123. Inoue T., Kimura T., Azuma C., Inazawa J., Takemura M., Kikuchi T., Kubota Y., Ogita K., Saji F. Structural organization of the human oxytocin receptor gene. J. Biol. Chem. 1994, 269:32451-32456.
124. Inoue H., Yamasue H., Tochigi M., Abe O., Liu X., Kawamura Y., Takei K., Suga M., Yamada H., Rogers M.A., Aoki S., Sasaki T., Kasai K. Association between the oxytocin receptor gene and amygdalar volume in healthy adults. Biol. Psychiatry 2010, 68:1066-1072.
125. Insel T.R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 2010, 65:768-779.
126. Israel S., Lerer E., Shalev I., Uzefovsky F., Reibold M., Bachner-Melman R., Granot R., Bornstein G., Knafo A., Yirmiya N., Ebstein R.P. Molecular genetic studies of the arginine vasopressin 1a receptor (AVPR1a) and the oxytocin receptor (OXTR) in human behaviour: from autism to altruism with some notes in between. Prog. Brain Res. 2008, 170:435-449.
127. Israel S., Lerer E., Shalev I., Uzefovsky F., Riebold M., Laiba E., Bachner-Melman R., Maril A., Bornstein G., Knafo A., Ebstein R.P. The oxytocin receptor (OXTR) contributes to prosocial fund allocations in the dictator game and the social value orientations task. PLoS One 2009, 4:e5535.
128. Jacob S., Brune C.W., Carter C.S., Leventhal B.L., Lord C., Cook E.H. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci. Lett. 2007, 417:6-9.
129. Jard S., Barberis C., Audigier S., Tribollet E. Neurohypophyseal hormone receptor systems in brain and periphery. Prog. Brain Res. 1987, 72:173-187.
130. Jin D., Liu H.X., Hirai H., Torashima T., Nagai T., Lopatina O., Shnayder N.A., Yamada K., Noda M., Seike T., Fujita K., Takasawa S., Yokoyama S., Koizumi K., Shiraishi Y., Tanaka S., Hashii M., Yoshihara T., Higashida K., Islam M.S., Yamada N., Hayashi K., Noguchi N., Kato I., Okamoto H., Matsushima A., Salmina A., Munesue T., Shimizu N., Mochida S., Asano M., Higashida H. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 2007, 446:41-45.
131. Johansson A., Bergman H., Corander J., Waldman I.D., Karrani N., Salo B., Jern P., Algars M., Sandnabba K., Santtila P., Westberg L. Alcohol and aggressive behavior in men-moderating effects of oxytocin receptor gene (OXTR) polymorphisms. Genes Brain Behav. 2011.
132. Kato S., Tora L., Yamauchi J., Masushige S., Bellard M., Chambon P. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TGACC-3' motifs acting synergistically. Cell 1992, 68:731-742.
133. Kawamura Y., Liu X., Akiyama T., Shimada T., Otowa T., Sakai Y., Kakiuchi C., Umekage T., Sasaki T., Akiskal H.S. The association between oxytocin receptor gene (OXTR) polymorphisms and affective temperaments, as measured by TEMPS-A. J. Affect. Disord. 2010, 127:31-37.
134. Kaye W.H. Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res. 1996, 62:65-74.
135. Kelemenova S., Schmidtova E., Ficek A., Celec P., Kubranska A., Ostatnikova D. Polymorphisms of candidate genes in Slovak autistic patients. Psychiatr. Genet. 2010, 20:137-139.
136. Keri S., Kiss I. Oxytocin response in a trust game and habituation of arousal. Physiol. Behav. 2011, 102:221-224.
137. Keri S., Kiss I., Kelemen O. Sharing secrets: oxytocin and trust in schizophrenia. Soc. Neurosci. 2008, 1-7.
138. Kim S.J., Young L.J., Gonen D., Veenstra-VanderWeele J., Courchesne R., Courchesne E., Lord C., Leventhal B.L., Cook E.H., Insel T.R. Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol. Psychiatry 2002, 7:503-507.
139. Kim H.S., Sherman D.K., Sasaki J.Y., Xu J., Chu T.Q., Ryu C., Suh E.M., Graham K., Taylor S.E. Culture, distress, and oxytocin receptor polymorphism (OXTR) interact to influence emotional support seeking. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15717-15721.
140. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Gruppe H., Mattay V.S., Gallhofer B., Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005, 25:11489-11493.
141. Klauck S.M., Poustka F., Benner A., Lesch K.P., Poustka A. Serotonin transporter (5-HTT) gene variants associated with autism?. Hum. Mol. Genet. 1997, 6:2233-2238.
142. Klimek M. Comparative analysis of ACTH and oxytocinase plasma concentration during pregnancy. Neuro Endocrinol. Lett. 2005, 26:337-341.
143. Knafo A., Israel S., Darvasi A., Bachner-Melman R., Uzefovsky F., Cohen L., Feldman E., Lerer E., Laiba E., Raz Y., Nemanov L., Gritsenko I., Dina C., Agam G., Dean B., Bornstein G., Ebstein R.P. Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes Brain Behav. 2008, 7:266-275.
144. Knafo A., Israel S., Ebstein R.P. Heritability of children's prosocial behavior and differential susceptibility to parenting by variation in the dopamine receptor D4 gene. Dev. Psychopathol. 2011, 23:53-67.
145. Knapp M., Romeo R., Beecham J. Economic cost of autism in the UK. Autism 2009, 13:317-336.
146. Kogan A., Saslow L.R., Impett E.A., Oveis C., Keltner D., Rodrigues Saturn S. Thin-slicing study of the oxytocin receptor (OXTR) gene and the evaluation and expression of the prosocial disposition. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19189-19192.
147. Koolhaas J.M., de Boer S.F., Coppens C.M., Buwalda B. Neuroendocrinology of coping styles: towards understanding the biology of individual variation. Front. Neuroendocrinol. 2010, 31:307-321.
148. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., Fehr E. Oxytocin increases trust in humans. Nature 2005, 435:673-676.
149. Kow L.M., Pfaff D.W. Vasopressin excites ventromedial hypothalamic glucose-responsive neurons in vitro. Physiol. Behav. 1986, 37:153-158.
150. Kozaki H., Itakura A., Okamura M., Ohno Y., Wakai K., Mizutani S. Maternal serum placental leucine aminopeptidase (P-LAP)/oxytocinase and preterm delivery. Int. J. Gynecol. Obstet. 2001, 73:207-213.
151. Kramer K.M., Cushing B.S., Carter C.S., Wu J., Ottinger M.A. Sex and species differences in plasma oxytocin using an enzyme immunoassay. Can. J. Zool. 2004, 82:1194-1200.
152. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
153. Kruger T.H., Haake P., Chereath D., Knapp W., Janssen O.E., Exton M.S., Schedlowski M., Hartmann U. Specificity of the neuroendocrine response to orgasm during sexual arousal in men. J. Endocrinol. 2003, 177:57-64.
154. Kruger T.H., Schiffer B., Eikermann M., Haake P., Gizewski E., Schedlowski M. Serial neurochemical measurement of cerebrospinal fluid during the human sexual response cycle. Eur. J. Neurosci. 2006, 24:3445-3452.
155. Kuratomi G., Iwamoto K., Bundo M., Kusumi I., Kato N., Iwata N., Ozaki N., Kato T. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol. Psychiatry 2008, 13:429-441.
156. Lachman H.M., Morrow B., Shprintzen R., Veit S., Parsia S.S., Faedda G., Goldberg R., Kucherlapati R., Papolos D.F. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am. J. Med. Genet. 1996, 67:468-472.
157. Landgraf R. Simultaneous measurement of arginine vasopressin and oxytocin in plasma and neurohypophyses by radioimmunoassay. Endokrinologie 1981, 78:191-204.
158. Landgraf R. Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocin. Exp. Clin. Endocrinol. 1985, 85:245-248.
159. Landgraf R. Mortyn Jones Memorial Lecture. Intracerebrally released vasopressin and oxytocin: measurement, mechanisms and behavioural consequences. J. Neuroendocrinol. 1995, 7:243-253.
160. Lang U.E., Hellweg R., Seifert F., Schubert F., Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry 2007, 62:530-535.
161. Langhans W., Delprete E., Scharrer E. Mechanisms of vasopressin's anorectic effect. Physiol. Behav. 1991, 49:169-176.
162. Lee R., Ferris C., Van de Kar L.D., Coccaro E.F. Cerebrospinal fluid oxytocin, life history of aggression, and personality disorder. Psychoneuroendocrinology 2009, 34(10):1567-1573.
163. Lennox R.-D., Wolfe R.-N. Revision of the self-monitoring scale. J. Pers. Soc. Psychol. 1984, 46:1349-1364.
164. Lerer E., Levi S., Salomon S., Darvasi A., Yirmiya N., Ebstein R.P. Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition. Mol. Psychiatry 2008, 13:980-988.
165. Lerer E., Yirmiya R., Salomon S., Ebstein R.P. Polymorphisms in the CD38 gene are associated with socialization skills in autism spectrum disorders and correlate with expression levels. Israel J. Psychiatry 2009, 46(41):S46. (42.45).
166. Lerer E., Levi S., Israel S., Yaari M., Nemanov L., Mankuta D., Nurit Y., Ebstein R.P. Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family-based study. Autism Res. 2010, 3:293-302.
167. Levin R., Heresco-Levy U., Bachner-Melman R., Israel S., Shalev I., Ebstein R.P. Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition. Psychoneuroendocrinology 2009, 34:901-908.
168. Levine A., Zagoory-Sharon O., Feldman R., Weller A. Oxytocin during pregnancy and early postpartum: individual patterns and maternal-fetal attachment. Peptides 2007, 28:1162-1169.
169. Liao W.X., Roy A.C., Biswas A., Arulkumaran S., Ratnam S.S. A new silent C to T polymorphism in the exon 3 of the oxytocin receptor gene. Clin. Genet. 1996, 50:533-534.
170. Liedman R., Hansson S.R., Howe D., Igidbashian S., McLeod A., Russell R.J., Akerlund M. Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects. Gynecol. Endocrinol. 2008, 24:508-513.
171. Light K.C., Smith T.E., Johns J.M., Brownley K.A., Hofheimer J.A., Amico J.A. Oxytocin responsivity in mothers of infants: a preliminary study of relationships with blood pressure during laboratory stress and normal ambulatory activity. Health Psychol. 2000, 19:560-567.
172. Light K.C., Grewen K.M., Amico J.A., Boccia M., Brownley K.A., Johns J.M. Deficits in plasma oxytocin responses and increased negative affect, stress, and blood pressure in mothers with cocaine exposure during pregnancy. Addict. Behav. 2004, 29:1541-1564.
173. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. Am. J. Hum. Genet. 2007, 80:531-538.
174. Lin Z., Reierstad S., Huang C.C., Bulun S.E. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res. 2007, 67:5017-5024.
175. Liu X., Kawamura Y., Shimada T., Otowa T., Koishi S., Sugiyama T., et al. Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. J. Hum. Genet. 2010, 55(3):137-141.
176. Loewenstein G., Rick S., Cohen J.D. Neuroeconomics. Annu. Rev. Psychol. 2008, 59:647-672.
177. Lucht M.J., Barnow S., Sonnenfeld C., Rosenberger A., Grabe H.J., Schroeder W., Volzke H., Freyberger H.J., Herrmann F.H., Kroemer H., Rosskopf D. Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:860-866.
178. Macdonald K., Macdonald T.M. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv. Rev. Psychiatry 2010, 18:1-21.
179. Maeda S., Kobayashi M.A., Araki S., Babazono T., Freedman B.I., Bostrom M.A., Cooke J.N., Toyoda M., Umezono T., Tarnow L., Hansen T., Gaede P., Jorsal A., Ng D.P., Ikeda M., Yanagimoto T., Tsunoda T., Unoki H., Kawai K., Imanishi M., Suzuki D., Shin H.D., Park K.S., Kashiwagi A., Iwamoto Y., Kaku K., Kawamori R., Parving H.H., Bowden D.W., Pedersen O., Nakamura Y. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet. 2010, 6:e1000842.
180. Maes M., Monteleone P., Bencivenga R., Goossens F., Maj M., van West D., Bosmans E., Scharpe S. Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa. Psychoneuroendocrinology 2001, 26:17-26.
181. Maher B.S., Vladimirov V.I., Latendresse S.J., Thiselton D.L., McNamee R., Kang M., et al. The AVPR1A gene and substance use disorders: association, replication, and functional evidence. Biol. Psychiatry 2011, 70(6):519-527.
182. Malavasi F., Deaglio S., Funaro A., Ferrero E., Horenstein A.L., Ortolan E., Vaisitti T., Aydin S. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 2008, 88:841-886.
183. Martineau J., Andersson F., Barthelemy C., Cottier J.P., Destrieux C. Atypical activation of the mirror neuron system during perception of hand motion in autism. Brain Res. 2010, 1320:168-175.
184. Matsumoto H., Nagasaka T., Hattori A., Rogi T., Tsuruoka N., Mizutani S., Tsujimoto M. Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides. Eur. J. Biochem. 2001, 268:3259-3266.
185. McCauley J.L., Li C., Jiang L., Olson L.M., Crockett G., Gainer K., Folstein S.E., Haines J.L., Sutcliffe J.S. Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates. BMC Med. Genet. 2005, 6:1.
186. McDermott R., Tingley D., Cowden J., Frazzetto G., Johnson D.D. Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2118-2123.
187. Menon S., Buteri J., Roy B., Murrell M., Quinlan S., Macmillan J.C., Lea R.A., Haupt L.M., Griffiths L.R. Association study of calcitonin gene-related polypeptide-alpha (CALCA) gene polymorphism with migraine. Brain Res. 2011, 1378:119-124.
188. Meyer-Lindenberg A., Kolachana B., Gold B., Olsh A., Nicodemus K.K., Mattay V., et al. Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol. Psychiatry 2009, 14(10):968-975.
189. Michelini S., Urbanek M., Dean M., Goldman D. Polymorphism and genetic mapping of the human oxytocin receptor gene on chromosome 3. Am. J. Med. Genet. 1995, 60:183-187.
190. Mizutani S., Yoshino M., Oya M. A comparison of oxytocinase and L-methionine-insensitive leucine aminopeptidase during normal pregnancy. Clin. Biochem. 1976, 9:228.
191. Mizutani S., Hayakawa H., Akiyama H., Sakura H., Yoshino M., Oya M., Kawashima Y. Simultaneous determinations of plasma oxytocin and serum placental leucine aminopeptidase (P-LAP) during late pregnancy. Clin. Biochem. 1982, 15:141-145.
192. Modahl C., Green L., Fein D., Morris M., Waterhouse L., Feinstein C., Levin H. Plasma oxytocin levels in autistic children. Biol. Psychiatry 1998, 43:270-277.
193. Montag C., Fiebach C.J., Kirsch P., Reuter M. Interaction of 5-HTTLPR and a variation on the oxytocin receptor gene influences negative emotionality. Biol. Psychiatry 2011, 69:601-603.
194. Munesue T., Yokoyama S., Nakamura K., Anitha A., Yamada K., Hayashi K., Asaka T., Liu H.X., Jin D., Koizumi K., Islam M.S., Huang J.J., Ma W.J., Kim U.H., Kim S.J., Park K., Kim D., Kikuchi M., Ono Y., Nakatani H., Suda S., Miyachi T., Hirai H., Salmina A., Pichugina Y.A., Soumarokov A.A., Takei N., Mori N., Tsujii M., Sugiyama T., Yagi K., Yamagishi M., Sasaki T., Yamasue H., Kato N., Hashimoto R., Taniike M., Hayashi Y., Hamada J., Suzuki S., Ooi A., Noda M., Kamiyama Y., Kido M.A., Lopatina O., Hashii M., Amina S., Malavasi F., Huang E.J., Zhang J., Shimizu N., Yoshikawa T., Matsushima A., Minabe Y., Higashida H. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci. Res. 2010, 67:181-191.
195. Murani E., Ponsuksili S., D'Eath R.B., Turner S.P., Kurt E., Evans G., Tholking L., Klont R., Foury A., Mormede P., Wimmers K. Association of HPA axis-related genetic variation with stress reactivity and aggressive behaviour in pigs. BMC Genet. 2010, 11:74.
196. Murata T., Murata E., Liu C.X., Narita K., Honda K., Higuchi T. Oxytocin receptor gene expression in rat uterus: regulation by ovarian steroids. J. Endocrinol. 2000, 166:45-52.
197. Muthukumaraswamy S.D., Johnson B.W. Changes in rolandic mu rhythm during observation of a precision grip. Psychophysiology 2004, 41:152-156.
198. Muthukumaraswamy S.D., Johnson B.W., McNair N.A. Mu rhythm modulation during observation of an object-directed grasp. Brain Res. Cogn. Brain Res. 2004, 19:195-201.
199. Nakada T.A., Russell J.A., Wellman H., Boyd J.H., Nakada E., Thain K.R., Thair S.A., Hirasawa H., Oda S., Walley K.R. Leucyl/Cystinyl aminopeptidase gene variants in septic shock. Chest 2011, 139:1042-1049.
200. Nakamura H., Itakuara A., Okamura M., Ito M., Iwase A., Nakanishi Y., Okada M., Nagasaka T., Mizutani S. Oxytocin stimulates the translocation of oxytocinase of human vascular endothelial cells via activation of oxytocin receptors. Endocrinology 2000, 141:4481-4485.
201. Nilsson U. Soothing music can increase oxytocin levels during bed rest after open-heart surgery: a randomised control trial. J. Clin. Nurs. 2009, 18:2153-2161.
202. Nishimura Y., Martin C.L., Vazquez-Lopez A., Spence S.J., Alvarez-Retuerto A.I., Sigman M., Steindler C., Pellegrini S., Schanen N.C., Warren S.T., Geschwind D.H. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum. Mol. Genet. 2007, 16:1682-1698.
203. Nomura S., Ito T., Yamamoto E., Sumigama S., Iwase A., Okada M., Shibata K., Ando H., Ino K., Kikkawa F., Mizutani S. Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy. Biochim. Biophys. Acta 2005, 1751:19-25.
204. Oberman L.M., Hubbard E.M., McCleery J.P., Altschuler E.L., Ramachandran V.S., Pineda J.A. EEG evidence for mirror neuron dysfunction in autism spectrum disorders. Brain Res. Cogn. Brain Res. 2005, 24:190-198.
205. Oberman L.M., Ramachandran V.S., Pineda J.A. Modulation of mu suppression in children with autism spectrum disorders in response to familiar or unfamiliar stimuli: the mirror neuron hypothesis. Neuropsychologia 2008, 46:1558-1565.
206. Oh S.H., Kim Y.H., Park S.M., Cho S.H., Park J.S., Jang A.S., Park S.W., Uh S.T., Lee Y.M., Kim M.K., Choi I.S., Hong C.S., Lee Y.W., Lee J.Y., Choi B.W., Park B.L., Shin H.D., Park C.S. Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. Pharmacogenomics 2011, 12:351-363.
207. O'Lone R., Frith M.C., Karlsson E.K., Hansen U. Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 2004, 18:1859-1875.
208. Opacka-Juffry J., Mohiyeddini C. Experience of stress in childhood negatively correlates with plasma oxytocin concentration in adult men. Stress 2012, 15(1):1-10.
209. Ozsoy S., Esel E., Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Res. 2009, 169:249-252.
210. Pandey G.N., Rizavi H.S., Dwivedi Y., Pavuluri M.N. Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:1077-1085.
211. Park J., Willmott M., Vetuz G., Toye C., Kirley A., Hawi Z., et al. Evidence that genetic variation in the oxytocin receptor (OXTR) gene influences social cognition in ADHD. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(4):697-702.
212. Parker K.J., Kenna H.A., Zeitzer J.M., Keller J., Blasey C.M., Amico J.A., Schatzberg A.F. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res. 2010, 178:359-362.
213. Perry A., Bentin S., Shalev I., Israel S., Uzefovsky F., Bar-On D., et al. Intranasal oxytocin modulates EEG mu/alpha and beta rhythms during perception of biological motion. Psychoneuroendocrinology 2010, 35(10):1446-1453.
214. Petrovic P., Kalisch R., Singer T., Dolan R.J. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J. Neurosci. 2008, 28:6607-6615.
215. Pham V., Burns P., Albiston A.L., Yeatman H.R., Ng L., Diwakarla S., Chai S.Y. Reproduction and maternal behavior in insulin-regulated aminopeptidase (IRAP) knockout mice. Peptides 2009, 30:1861-1865.
216. Pineda J.A. The functional significance of mu rhythms: translating "seeing" and "hearing" into "doing". Brain Res. Brain Res. Rev. 2005, 50:57-68.
217. Prichard Z.M., Mackinnon A.J., Jorm A.F., Easteal S. AVPR1A and OXTR polymorphisms are associated with sexual and reproductive behavioral phenotypes in humans. Mutation in brief no. 981. Online. Hum. Mutat. 2007, 28(11):1150.
218. Raistrick C.A., Day I.N., Gaunt T.R. Genome-wide data-mining of candidate human splice translational efficiency polymorphisms (STEPs) and an online database. PLoS One 2010, 5:e13340.
219. Rao V.V., Loffler C., Battey J., Hansmann I. The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenet. Cell Genet. 1992, 61:271-273.
220. Riebold M., Mankuta D., Lerer E., Israel S., Zhong S., Nemanov L., Monakhov M.V., Levi S., Yirmiya N., Yaari M., Malavasi F., Ebstein R.P. All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from autism spectrum disorder. Mol. Med. 2011, 17:799-806.
221. Riem M.M., Bakermans-Kranenburg M.J., Pieper S., Tops M., Boksem M.A., Vermeiren R.R., et al. Oxytocin modulates amygdala, insula, and inferior frontal gyrus responses to infant crying: a randomized controlled trial. Biol. Psychiatry 2011, 70(3):291-297.
222. Rissman E.F. Roles of oestrogen receptors alpha and beta in behavioural neuroendocrinology: beyond Yin/Yang. J. Neuroendocrinol. 2008, 20:873-879.
223. Rizzolatti G., Fabbri-Destro M., Cattaneo L. Mirror neurons and their clinical relevance. Nat. Clin. Pract. Neurol. 2009, 5:24-34.
224. Rodrigues S.M., Saslow L.R., Garcia N., John O.P., Keltner D. Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(50):21437-21441.
225. Ronald A., Edelson L.R., Asherson P., Saudino K.J. Exploring the relationship between autistic-like traits and ADHD behaviors in early childhood: findings from a community twin study of 2-year-olds. J. Abnorm. Child Psychol. 2010, 38:185-196.
226. Roper J., O'Carroll A.M., Young W., Lolait S. The vasopressin Avpr1b receptor: molecular and pharmacological studies. Stress 2011, 14:98-115.
227. Rubin L.H., Carter C.S., Drogos L., Jamadar R., Pournajafi-Nazarloo H., Sweeney J.A., Maki P.M. Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia. Schizophr. Res. 2011, 130:266-270.
228. Sakai J.T., Crowley T.J., Stallings M.C., Matthew M., Hewitt J.K., Hopfer C., Hoft N.R., Ehringer M.A. Test of association between 10 single nucleotide polymorphisms in the oxytocin receptor gene and conduct disorder. Psychiatr. Genet. 2011, (online advanced publication).
229. Sala M., Braida D., Lentini D., Busnelli M., Bulgheroni E., Capurro V., Finardi A., Donzelli A., Pattini L., Rubino T., Parolaro D., Nishimori K., Parenti M., Chini B. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 2011, 69:875-882.
230. Salmina A.B., Lopatina O., Ekimova M.V., Mikhutkina S.V., Higashida H. CD38/cyclic ADP-ribose system: a new player for oxytocin secretion and regulation of social behaviour. J. Neuroendocrinol. 2010, 22(5):380-392.
231. Salonia A., Nappi R.E., Pontillo M., Daverio R., Smeraldi A., Briganti A., Fabbri F., Zanni G., Rigatti P., Montorsi F. Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm. Behav. 2005, 47:164-169.
232. Sanfey A.G. Social decision-making: insights from game theory and neuroscience. Science 2007, 318:598-602.
233. Saphire-Bernstein S., Way B.M., Kim H.S., Sherman D.K., Taylor S.E. Oxytocin receptor gene (OXTR) is related to psychological resources. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15118-15122.
234. Sartorius A., Hellweg R., Litzke J., Vogt M., Dormann C., Vollmayr B., Danker-Hopfe H., Gass P. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009, 42:270-276.
235. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Marechal P., Pequeux C., Ansseau M., Legros J.J. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 2007, 32:407-410.
236. Scattoni M.L., McFarlane H.G., Zhodzishsky V., Caldwell H.K., Young W.S., Ricceri L., Crawley J.N. Reduced ultrasonic vocalizations in vasopressin 1b knockout mice. Behav. Brain Res. 2008, 187:371-378.
237. Schultz W. Introduction. Neuroeconomics: the promise and the profit. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3767-3769.
238. Shamay-Tsoory S.G. The neural bases for empathy. Neuroscientist 2011, 17:18-24.
239. Shao Y., Wolpert C.M., Raiford K.L., Menold M.M., Donnelly S.L., Ravan S.A., Bass M.P., McClain C., von Wendt L., Vance J.M., Abramson R.H., Wright H.H., Ashley-Koch A., Gilbert J.R., DeLong R.G., Cuccaro M.L., Pericak-Vance M.A. Genomic screen and follow-up analysis for autistic disorder. Am. J. Med. Genet. 2002, 114:99-105.
240. Singer T., Snozzi R., Bird G., Petrovic P., Silani G., Heinrichs M., Dolan R.J. Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain. Emotion 2008, 8:781-791.
241. Skrundz M., Bolten M., Nast I., Hellhammer D.H., Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology 2011, 36:1886-1893.
242. Sparrow S., Balla D., Cicchetti D. Vineland Adaptive Behavior Scales Interview Edition Expanded Form Manual 1984, American Guidance Services Inc., Circle Pines, MN.
243. Sparrow S.S., Balla D.A., Cicchetti D.V. Vineland Adaptive Behavior Scales 1984, American Guidance Services, Minneapolis, Minnesota.
244. Sribudiani Y., Metzger M., Osinga J., Rey A., Burns A.J., Thapar N., Hofstra R.M. Variants in RET associated with Hirschsprung's disease affect binding of transcription factors and gene expression. Gastroenterology 2011, 140(572-582):e572.
245. Stevens T.A., Iacovoni J.S., Edelman D.B., Meech R. Identification of novel binding elements and gene targets for the homeodomain protein BARX2. J. Biol. Chem. 2004, 279:14520-14530.
246. Striepens N., Kendrick K.M., Maier W., Hurlemann R. Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Front Neuroendocrinol. 2011, 32(4):426-450.
247. Succu S., Sanna F., Argiolas A., Melis M.R. Oxytocin injected into the hippocampal ventral subiculum induces penile erection in male rats by increasing glutamatergic neurotransmission in the ventral tegmental area. Neuropharmacology 2011, 61(1-2):181-188.
248. Summar M.L., Phillips J.A., Battey J., Castiglione C.M., Kidd K.K., Maness K.J., Weiffenbach B., Gravius T.C. Linkage relationships of human arginine vasopressin-neurophysin-II and oxytocin-neurophysin-I to prodynorphin and other loci on chromosome 20. Mol. Endocrinol. 1990, 4:947-950.
249. Szczepanska-Sadowska E. Role of neuropeptides in central control of cardiovascular responses to stress. J. Physiol. Pharmacol. 2008, 59(Suppl 8):61-89.
250. Szeto A., McCabe P.M., Nation D.A., Tabak B.A., Rossetti M.A., McCullough M.E., Schneiderman N., Mendez A.J. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom. Med. 2011, 73:393-400.
251. Tanioka T., Hattori A., Masuda S., Nomura Y., Nakayama H., Mizutani S., Tsujimoto M. Human leukocyte-derived arginine aminopeptidase. The third member of the oxytocinase subfamily of aminopeptidases. J. Biol. Chem. 2003, 278:32275-32283.
252. Tansey K.E., Brookes K.J., Hill M.J., Cochrane L.E., Gill M., Skuse D., et al. Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: genetic and molecular studies. Neurosci. Lett. 2010, 474(3):163-167.
253. Tansey K.E., Hill M.J., Cochrane L.E., Gill M., Anney R.J., Gallagher L. Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autism. Mol Autism 2011, 2:3.
254. Taylor S.E., Saphire-Bernstein S., Seeman T.E. Are plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships?. Psychol. Sci. 2010, 21:3-7.
255. Terrillon S., Durroux T., Mouillac B., Breit A., Ayoub M.A., Taulan M., Jockers R., Barberis C., Bouvier M. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol. Endocrinol. 2003, 17:677-691.
256. Thibonnier M. Genetics of vasopressin receptors. Curr. Hypertens. Rep. 2004, 6:21-26.
257. Thibonnier M., Auzan C., Madhun Z., Wilkins P., Berti-Mattera L., Clauser E. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J. Biol. Chem. 1994, 269:3304-3310.
258. Thibonnier M., Graves M.K., Wagner M.S., Auzan C., Clauser E., Willard H.F. Structure, sequence, expression, and chromosomal localization of the human V1a vasopressin receptor gene. Genomics 1996, 31:327-334.
259. Thibonnier M., Coles P., Thibonnier A., Shoham M. The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 2001, 41:175-202.
260. Thompson P.M., Martin N.G., Wright M.J. Imaging genomics. Curr. Opin. Neurol. 2010, 23:368-373.
261. Thompson R.J., Parker K.J., Hallmayer J.F., Waugh C.E., Gotlib I.H. Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology 2011, 36:144-147.
262. Tops M., van Ijzendoorn M.H., Riem M.M., Boksem M.A., Bakermans-Kranenburg M.J. Oxytocin receptor gene associated with the efficiency of social auditory processing. Front Psychiatry 2011, 2:60.
263. Tost H., Kolachana B., Hakimi S., Lemaitre H., Verchinski B.A., Mattay V.S., et al. A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(31):13936-13941.
264. Tseng M., Alda M., Xu L., Sun X., Wang J.F., Grof P., Turecki G., Rouleau G., Young L.T. BDNF protein levels are decreased in transformed lymphoblasts from lithium-responsive patients with bipolar disorder. J. Psychiatry Neurosci. 2008, 33:449-453.
265. Tsujimoto M., Hattori A. The oxytocinase subfamily of M1 aminopeptidases. Biochim. Biophys. Acta 2005, 1751:9-18.
266. Turner R.A., Altemus M., Yip D.N., Kupferman E., Fletcher D., Bostrom A., Lyons D.M., Amico J.A. Effects of emotion on oxytocin, prolactin, and ACTH in women. Stress 2002, 5:269-276.
267. Ukkola L.T., Onkamo P., Raijas P., Karma K., Jarvela I. Musical aptitude is associated with AVPR1A-haplotypes. PLoS One 2009, 4:e5534.
268. Van Lange P.A.M. The pursuit of joint outcomes and equality in outcomes: An integrative model of social value orientation. J. Pers. Soc. Psychol. 1999, 77:337-349.
269. Van Lange P.A.M., De Bruin E.M.N., Otten W., Joireman J.A. Development of prosocial, individualistic, and competitive orientations: Theory and preliminary evidence. J. Pers. Soc. Psychol. 1997, 73:733-746.
270. Van Lange P.A.M., Bekkers R., Schuyt T.N.M., Vugt M.V. From games to giving: Social value orientation predicts donations to noble causes. Basic Appl. Soc. Psychol. 2007, 29:375-384.
271. van West D., Del-Favero J., Deboutte D., Van Broeckhoven C., Claes S. Arginine vasopressin receptor gene-based single-nucleotide polymorphism analysis in attention deficit hyperactivity disorder. Psychiatr. Genet. 2009, 19:102-103.
272. Viero C., Shibuya I., Kitamura N., Verkhratsky A., Fujihara H., Katoh A., Ueta Y., Zingg H.H., Chvatal A., Sykova E., Dayanithi G. REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy. CNS Neurosci. Ther. 2010, 16:e138-e156.
273. Volpi S., Rabadan-Diehl C., Cawley N., Aguilera G. Transcriptional regulation of the pituitary vasopressin V1b receptor involves a GAGA-binding protein. J. Biol. Chem. 2002, 277:27829-27838.
274. Walker S.J., Segal J., Aschner M. Cultured lymphocytes from autistic children and non-autistic siblings up-regulate heat shock protein RNA in response to thimerosal challenge. Neurotoxicology 2006, 27:685-692.
275. Walum H., Westberg L., Henningsson S., Neiderhiser J.M., Reiss D., Igl W., Ganiban J.M., Spotts E.L., Pedersen N.L., Eriksson E., Lichtenstein P. Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14153-14156.
276. Walum H., Lichtenstein P., Neiderhiser J.M., Reiss D., Ganiban J.M., Spotts E.L., Pedersen N.L., Anckarsater H., Larsson H., Westberg L. Variation in the Oxytocin Receptor Gene Is Associated with Pair-Bonding and Social Behavior. Biol. Psychiatry 2011, (advanced online publication).
277. Wang Q., Carroll J.S., Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell 2005, 19:631-642.
278. Wang D., Guo Y., Wrighton S.A., Cooke G.E., Sadee W. Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs. Pharmacogenomics J. 2011, 11:274-286.
279. Wassink T.H., Piven J., Vieland V.J., Pietila J., Goedken R.J., Folstein S.E., Sheffield V.C. Examination of AVPR1a as an autism susceptibility gene. Mol. Psychiatry 2004, 9:968-972.
280. Way B.M., Taylor S.E., Eisenberger N.I. Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15079-15084.
281. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., Straub R.E., Weinberger D.R., Kleinman J.E. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum. Mol. Genet. 2008, 17:2293-2309.
282. Wells J., Farnham P.J. Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 2002, 26:48-56.
283. Wermter A.K., Kamp-Becker I., Hesse P., Schulte-Korne G., Strauch K., Remschmidt H. Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:629-639.
284. Wersinger S.R., Kelliher K.R., Zufall F., Lolait S.J., O'Carroll A.M., Young W.S. Social motivation is reduced in vasopressin 1b receptor null mice despite normal performance in an olfactory discrimination task. Horm. Behav. 2004, 46:638-645.
285. Winslow J.T., Insel T.R. The social deficits of the oxytocin knockout mouse. Neuropeptides 2002, 36:221-229.
286. Wotjak C.T., Ganster J., Kohl G., Holsboer F., Landgraf R., Engelmann M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 1998, 85:1209-1222.
287. Wright J.W., Yamamoto B.J., Harding J.W. Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Prog. Neurobiol. 2008, 84:157-181.
288. Wu S., Jia M., Ruan Y., Liu J., Guo Y., Shuang M., Gong X., Zhang Y., Yang X., Zhang D. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol. Psychiatry 2005, 58:74-77.
289. Xue Q., Zhou Y.F., Zhu S.N., Bulun S.E. Hypermethylation of the CpG island spanning from exon II to intron III is associated with steroidogenic factor 1 expression in stromal cells of endometriosis. Reprod. Sci. 2011, 18:1080-1084.
290. Yang S.Y., Cho S.C., Yoo H.J., Cho I.H., Park M., Yoe J., et al. Family-based association study of microsatellites in the 5' flanking region of AVPR1A with autism spectrum disorder in the Korean population. Psychiatry Res. 2010, 178(1):199-201.
291. Yarkov A., Montero S., Lemus M., Roces de Alvarez-Buylla E., Alvarez-Buylla R. Arginine-vasopressin in nucleus of the tractus solitarius induces hyperglycemia and brain glucose retention. Brain Res. 2001, 902:212-222.
292. Yirmiya N., Pilowsky T., Nemanov L., Arbelle S., Feinsilver T., Fried I., Ebstein R.P. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am. J. Med. Genet. 2001, 105:381-386.
293. Yirmiya N., Rosenberg C., Levi S., Salomon S., Shulman C., Nemanov L., Dina C., Ebstein R.P. Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Mol. Psychiatry 2006, 11:488-494.
294. Ylisaukko-oja T., Rehnstrom K., Auranen M., Vanhala R., Alen R., Kempas E., Ellonen P., Turunen J.A., Makkonen I., Riikonen R., Nieminen-von Wendt T., von Wendt L., Peltonen L., Jarvela I. Analysis of four neuroligin genes as candidates for autism. Eur. J. Hum. Genet. 2005, 13:1285-1292.
295. Ylisaukko-oja T., Alarcon M., Cantor R.M., Auranen M., Vanhala R., Kempas E., von Wendt L., Jarvela I., Geschwind D.H., Peltonen L. Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families. Ann. Neurol. 2006, 59:145-155.
296. Young L.J. Regulating the social brain: a new role for CD38. Neuron 2007, 54:353-356.
297. Young S.F., Griffante C., Aguilera G. Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell. Mol. Neurobiol. 2007, 27:439-461.
298. Yrigollen C.M., Han S.S., Kochetkova A., Babitz T., Chang J.T., Volkmar F.R., Leckman J.F., Grigorenko E.L. Genes controlling affiliative behavior as candidate genes for autism. Biol. Psychiatry 2008, 63:911-916.
299. Zak P.J., Kurzban R., Matzner W.T. Oxytocin is associated with human trustworthiness. Horm. Behav. 2005, 48:522-527.
300. Zeichner A., Frey F.C., Parrott D.J., Butryn M.F. Measurement of laboratory aggression: a new response-choice paradigm. Psychol. Rep. 1999, 85:1229-1237.
301. Zhong S., Chew S.H., Set E., Zhang J., Xue H., Sham P.C., Ebstein R.P., Israel S. The heritability of attitude toward economic risk. Twin Res. Hum. Genet. 2009, 12:103-107.
302. Zhong S., Israel S., Xue H., Ebstein R.P., Chew S.H. Monoamine oxidase A gene (MAOA) associated with attitude towards longshot risks. PLoS One 2009, 4:e8516.
303. Zhong S., Israel S., Xue H., Sham P.C., Ebstein R.P., Chew S.H. A neurochemical approach to valuation sensitivity over gains and losses. Proc Biol Sci 2009, 276:4181-4188.
304. Zhong S., Israel S., Shalev I., Xue H., Ebstein R.P., Chew S.H. Dopamine D4 receptor gene associated with fairness preference in ultimatum game. PLoS One 2010, 5:e13765.
305. Zhong S., Chark R., Ebstein R.P., Chew S.H. Imaging genetics for utility of risks over gains and losses. Neuroimage 2012, 59(1):540-546.
306. Zollner S., Pritchard J.K. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am. J. Hum. Genet. 2007, 80:605-615.